Improving Patient Understanding of Their Prostate Cancer Diagnosis Using AI
Can Artificial Intelligence Help Improve Patient Understanding of Their Diagnosis? Using ChatGPT as an Interactive Chatbot for Patients With Localized Prostate Cancer, a Feasibility Study
1 other identifier
interventional
50
1 country
1
Brief Summary
The purpose of this study is to determine if ChatGPT (an artificial intelligence driven chatbot) can help patients better understand their own pathology results and prostate cancer diagnosis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable prostate-cancer
Started Jun 2026
Shorter than P25 for not_applicable prostate-cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 6, 2025
CompletedFirst Posted
Study publicly available on registry
June 27, 2025
CompletedStudy Start
First participant enrolled
June 1, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2027
Study Completion
Last participant's last visit for all outcomes
January 1, 2027
April 30, 2026
April 1, 2026
7 months
June 6, 2025
April 27, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Accuracy as assessed by the rate of correctly identified and risk-stratified participants diagnosed with prostate cancer
Post intervention(approximately 70 minutes)
Secondary Outcomes (3)
Patient anxiety as measured by Visual analog scale(VAS-A)
Baseline and post intervention(approximately 70 minutes)
Understandability of diagnosis as measured by EORTC QLQ-INFO25
Baseline and post intervention(approximately 70 minutes)
Understandability of Chat GPT as assessed by Patient Education Materials Assessment Tool(PEMAT)
Post intervention(approximately 70 minutes)
Study Arms (1)
Chat GPT - Prostate Pathology Guide
EXPERIMENTALInterventions
On the date of appointment, participants will be given up to 30 minutes, to interact with a pre-prompted Chat GPT (Prostate Pathology Guide) using a Cleveland clinic device.
Eligibility Criteria
You may qualify if:
- Participants must be \>18 years or age
- Participants must have received a prostate biopsy at Cleveland Clinic main campus within the last 30 days, and have not received follow-up on their pathology results
- Participants must be willing to attend an in-person follow-up to review their pathology
- Participants must be English speaking
- Participants must provide informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Case Comprehensive Cancer Center, Cleveland Clinic Glickman Urologic Institute
Cleveland, Ohio, 44195, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Zeyad Schwen, MD
Case Comprehensive Cancer Center, Cleveland Clinic Glickman Urologic Institute
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 6, 2025
First Posted
June 27, 2025
Study Start (Estimated)
June 1, 2026
Primary Completion (Estimated)
January 1, 2027
Study Completion (Estimated)
January 1, 2027
Last Updated
April 30, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share